Logo image
HLA-A2--matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/[gamma][c.sup.null]/HLA-A2 transgenic mice concurrent with the expansion of islet-specific [CD8.sup.+] T cells.(ORIGINAL ARTICLE)
Journal article   Open access   Peer reviewed

HLA-A2--matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/[gamma][c.sup.null]/HLA-A2 transgenic mice concurrent with the expansion of islet-specific [CD8.sup.+] T cells.(ORIGINAL ARTICLE)

Fatima Whitfield-Larry, Ellen F Young, Garrick Talmage, Elizabeth Fudge, Anita Azam, Shipra Patel, Joseph Largay, Warren Byrd, John Buse, Ali S Calikoglu, …
Diabetes (New York, N.Y.), v 60(6), p1726
01 Jun 2011
url
https://doi.org/10.2337/db10-1287View
Published, Version of Record (VoR) Open

Abstract

Genetic aspects Histocompatibility antigens HLA antigens HLA histocompatibility antigens Pancreatic beta cells Physiological aspects Risk factors T cells Type 1 diabetes
OBJECTIVE--Type 1 diabetes is an autoimmune disease characterized by the destruction of insulin-producing [beta]-cells. NOD mice provide a useful tool for understanding disease pathogenesis and progression. Although much has been learned from studies with NOD mice, increased understanding of human type 1 diabetes can be gained by evaluating the pathogenic potential of human diabetogenic effector cells in vivo. Therefore, our objective in this study was to develop a small-animal model using human effector cells to study type 1 diabetes. RESEARCH DESIGN AND METHODS--We adoptively transferred HLA-A2-matched peripheral blood mononuclear cells (PBMCs) from type 1 diabetic patients and nondiabetic control subjects into transgenie NOD-scid/[sub.[gamma][c.sup.null]/HLA-A*0201 (NOD-scid/ [gamma][c.sup.null]/A2) nuce. At various times after adoptive transfer, we determined the ability of these mice to support the survival and proliferation of the human lymphoid cells. Human lymphocytes were isolated and assessed from the blood, spleen, pancreatic lymph node and islets of NOD-scid/[gamma][c.sup.null]/A2 mice after transfer. RESULTS--Human T and B cells proliferate and survive for at least 6 weeks and were recovered from the blood, spleen, draining pancreatic lymph node, and most importantly, islets of NOD-scid/[gamma][c.sup.null]/A2 mice. Lymphocytes from type 1 diabetic patients preferentially infiltrate the islets of NOD-scid/[gamma][c.sup.null]/A2 mice. In contrast, PBMCs from nondiabetic HLA-A2-matched donors showed significantly less islet infiltration. Moreover, in mice that received PBMCs from type 1 diabetic patients, we identiffed epitope-specific [CD8.sup.+] T cells among the islet infiltrates. CONCLUSIONS--We show that insulitis is transferred to NODscid/[gamma][c.sup.null]/A2 mice that received HLA-A2-matched PBMCs from type 1 diabetic patients. In addition, many of the infiltrating [CD8.sup.+] T cells are epitope-specific and produce interferon-[gamma] after in vitro peptide stimulation. This indicates that NOD-scid/[gamma][c.sup.null]/A2 mice transferred with HLA-A2-matched PBMCs from type 1 diabetic patients may serve as a useful tool for studying epitope-specific T-cell-mediated responses in patients with type 1 diabetes.

Metrics

6 Record Views
27 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Endocrinology & Metabolism
Logo image